Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cinpathogen is a specialized medical diagnostic company established as a joint venture between Kindstar Global and the University of Cincinnati College of Medicine. Headquartered in Beijing, the company focuses on providing advanced esoteric diagnostic testing services, particularly in the fields of pathology and molecular diagnostics, to the Chinese healthcare market. By integrating the academic and clinical expertise of the University of Cincinnati with Kindstar's extensive logistics and service network, Cinpathogen supports personalized medicine and provides high-quality diagnostic data for clinicians and pharmaceutical companies. The company plays a significant role in bridging Western medical technology with Chinese clinical needs, offering state-of-the-art testing for oncology, hematology, and infectious diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cinpathogen.